2m 2m 2m 2m 2m 2m 2m
ELANC ANIML HLTH (ELAN)
NYSE
$24.25+$0.28 (+1.16%)
Price as of Aug 21, 2026 7:58 PM EDT- $12.0BMarket Cap
- 33.84%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ELANC ANIML HLTH (ELAN)
$24.25+$0.28 (+1.16%)
ELAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.97 | ||
Change | +$0.41 (+1.74%) | ||
Open | $23.91 | ||
High | $24.15 | ||
Low | $23.68 | ||
Previous Close | $23.56 | ||
Volume | 4,757,078 | ||
30-Day Average Volume | 8,136,443 | ||
1-Week Change | 1.27% | ||
1-Month Change | -5.93% | ||
1-Year Change | 33.84% | ||
3-Year Change | 105.05% | ||
5-Year Change | -23.90% | ||
Fundamentals | |||
Shares Outstanding | 499.6M | ||
Total Assets | $13.6B | ||
Market Cap | $12.0B | ||
Enterprise Value | $15.4B | ||
Period: QTR TTM FY | |||
Revenue | $1.4B | ||
Net Income | $54.0M | ||
Free Cash Flow | $244.0M | ||
EBIT | $56.0M | ||
EBITDA | $227.0M | ||
Net Working Capital | $1.9B | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 68 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 2 | ||
P/E | 218 | ||
PEG | N/A | ||
Price/Free Cash Flow | 49 | ||
Price/Operating Cash Flow | 43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue